Glaxo Investing Here - After All!

Remain campaigners argued during the referendum campaign that investment would be hit if Britain quit the EU. Glaxo chief executive Sir Andrew Witty was among those warning against a vote to leave – claiming before the referendum that the UK would be ‘much better off inside the EU than outside’. But Glaxo yesterday said it will now spend £275million updating three manufacturing sites in Scotland, County Durham and Hertfordshire to beef up production of its medicines. The investment is a boost for the 2,750 people who work at the three plants and is likely to see hundreds more jobs created in the coming years. Mail